Root Financial Partners’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
Other funds holding MLYS
Root Financial Partners's MLYS Position: Q3 2026 in Review
Root Financial Partners opened a new position in Mineralys Therapeutics (MLYS) in Q3 2026: 25 shares worth $628. The stake represents ﹤0.01% of the portfolio and ranks #3136 among its holdings.
219 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.
- Root Financial Partners held 25 shares of Mineralys Therapeutics worth $628 as of Q3 2026.
- Mineralys Therapeutics was a new Root Financial Partners position in Q3 2026.
- Mineralys Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3136 holding.
- 219 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.
Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.